Monthly Triple-Drug Combo Lowers Immune Reactions in Leprosy
TOPLINE: Monthly rifampin-moxifloxacin-minocycline (RMM) therapy was associated with a lower risk for type 1 immunologic reactions than multidrug therapy (MDT) in patients with leprosy (Hansen disease [HD]) in a study. METHODOLOGY: Researchers conducted a …